AT-Patch (ATP-C130/ATP-C70) vs Irregular Rhythm Notification Feature (IRNF)
AI Verdict
Choose AT-Patch (ATP-C130/ATP-C70) if…
Choose AT-Patch if a physician requires a high-accuracy, continuous ECG recording for up to 14 days to diagnose intermittent arrhythmias, leveraging medical-grade data and integrated AI-powered analysis software. This tool is ideal for clinical settings where detailed, long-term cardiac monitoring and a comprehensive diagnostic report are essential for patient management.
View AT-Patch (ATP-C130/ATP-C70) →Choose Irregular Rhythm Notification Feature (IRNF) if…
Choose the Irregular Rhythm Notification Feature if an individual seeks a convenient, over-the-counter solution for proactive, ongoing screening for irregular heart rhythms suggestive of AFib, integrated with their Apple Watch. This feature is best suited for general heart health awareness and empowering users to initiate discussions with their physicians based on potential early indicators.
View Irregular Rhythm Notification Feature (IRNF) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AT-Patch (ATP-C130/ATP-C70) | Irregular Rhythm Notification Feature (IRNF) |
|---|---|---|
| Pricing | N/a | Included with apple watch purchase |
| Deployment | Wearable device for patients; analysis software deployed on-premise at medical institutions. | Device-based (Apple Watch), integrated with the iPhone Health app. |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Irregular Rhythm Notification Feature (IRNF)Apple's IRNF is integrated into a widely adopted consumer device (Apple Watch) with a familiar and intuitive user interface, making it highly accessible for proactive, continuous heart health screening in daily life. While AT-Patch is designed for comfortable wear during its diagnostic period, IRNF's seamless integration into the Apple ecosystem and over-the-counter availability give it an edge for general user usability.
Clinical Value
AT-Patch (ATP-C130/ATP-C70)AT-Patch offers up to 14 days of continuous, high-accuracy ECG monitoring with integrated AI-powered analysis software for comprehensive arrhythmia detection, providing a more robust diagnostic output for clinicians. In contrast, IRNF is a screening tool that identifies irregular rhythms suggestive of AFib, prompting users to seek medical advice rather than providing a definitive diagnosis.
Pricing & Value
Irregular Rhythm Notification Feature (IRNF)The Irregular Rhythm Notification Feature (IRNF) is included with the purchase of an Apple Watch, offering significant value to consumers as an 'always-on' heart health screening tool without additional cost. AT-Patch's pricing is not publicly available and typically involves direct sales to medical institutions, making its value proposition different and less transparent for the individual user.
Enterprise Readiness
AT-Patch (ATP-C130/ATP-C70)AT-Patch's analysis software is deployed on-premise at medical institutions, indicating its design for integration into clinical workflows and enterprise healthcare systems. Apple explicitly states it does not offer a Business Associate Agreement (BAA) for IRNF or HealthKit data, which is a significant barrier for healthcare organizations handling Protected Health Information (PHI) under HIPAA.
Innovation
Irregular Rhythm Notification Feature (IRNF)IRNF demonstrates greater innovation by democratizing AFib screening, integrating an FDA-cleared medical feature into a widely adopted consumer device for continuous, passive monitoring outside traditional clinical settings. While AT-Patch offers advanced diagnostic capabilities, IRNF's approach represents a more disruptive shift in population health monitoring.
Support & Docs
Irregular Rhythm Notification Feature (IRNF)Apple's IRNF provides an explicit 'onboarding process with educational materials' and leverages Apple's extensive, user-friendly support ecosystem, making documentation and assistance readily accessible for end-users. While AT-Patch would have professional support for medical institutions, the JSON and web search do not provide comparable details on user-facing support and documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AT-Patch (ATP-C130/ATP-C70) | Irregular Rhythm Notification Feature (IRNF) |
|---|---|---|
| Product Name | AT-Patch (ATP-C130/ATP-C70) | Irregular Rhythm Notification Feature (IRNF) |
| Company | ATsens Co. | Apple |
| Monitoring Approach | Up to 14 days of continuous ECG monitoring (ATP-C130) | Background heart rhythm checks during periods of stillness |
| Key Detection Capability | Continuous cardiac monitoring with AI/machine learning algorithms for ECG analysis and enhanced arrhythmia detection. | Irregular rhythm detection suggestive of AFib, with machine learning-based algorithm for improved AFib differentiation (IRNF 2.0). |
| Design Features | Shower-proof design (IP57 for ATP-C130, IP44 for ATP-C70), compact and lightweight (13g), no charging or electrode replacement required during monitoring. | Not specified |
Videos
Demos, reviews, and walkthroughs featuring AT-Patch (ATP-C130/ATP-C70) and Irregular Rhythm Notification Feature (IRNF).
Frequently Asked Questions
More Comparisons
More matchups featuring AT-Patch (ATP-C130/ATP-C70) or Irregular Rhythm Notification Feature (IRNF)
- Irregular Rhythm Notification Feature (IRNF) vs Sleepiz One+
- Irregular Rhythm Notification Feature (IRNF) vs EchoNext
- EchoConfidence (USA) vs Irregular Rhythm Notification Feature (IRNF)
- AT-Patch (ATP-C130/ATP-C70) vs EchoNext
- AT-Patch (ATP-C130/ATP-C70) vs Sleepiz One+
- Analytic for Hemodynamic Instability (AHI) vs Irregular Rhythm Notification Feature (IRNF)
Backers
Who funded each tool's parent company.